Where is the focus on hepatitis C research after the introduction of DAAs: To Understand, knowledge, prevent or cure hepatitis C?

Ann Hepatol. 2020 Mar-Apr;19(2):119-120. doi: 10.1016/j.aohep.2020.02.002.

Authors

Ana M Rivas-Estilla¹, Sonia A Lozano-Sepulveda²

Affiliations

¹ Biochemistry and Molecular Medicine Department, School of Medicine, Universidad Autónoma de Nuevo León, Monterrey, NL, México. Electronic address: amrivas1@yahoo.ca.
² Biochemistry and Molecular Medicine Department, School of Medicine, Universidad Autónoma de Nuevo León, Monterrey, NL, México.

PMID: 32138868
DOI: 10.1016/j.aohep.2020.02.002

No abstract available

Publication types

Editorial

MeSH terms

Antiviral Agents / therapeutic use
Asymptomatic Infections
Biomedical Research*
Blood Banks
Blood Transfusion / standards
Carcinoma, Hepatocellular / epidemiology
Carcinoma, Hepatocellular / etiology
Cross Infection / prevention & control
Drug Development
Drug Resistance, Viral
Gastroenterology*
Hepacivirus
Hepatitis C* / complications
Hepatitis C* / drug therapy
Hepatitis C* / prevention & control
Humans
Liver Neoplasms / epidemiology
Liver Neoplasms / etiology
Research Support as Topic
Viral Hepatitis Vaccines / therapeutic use

Substances

Antiviral Agents
Viral Hepatitis Vaccines